{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:25:23Z","timestamp":1790144723795,"version":"4.0.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report a case of Bietti crystalline retinal dystrophy with cystoid macular edema (CME) that was successfully treated with topical carbonic anhydrase inhibitor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A 35-year-old otherwise healthy woman, with a known case of Bietti crystalline retinal dystrophy, presented with progressive visual impairment in her right eye for 3 months. The best-corrected visual acuity was 20\/50 in the right eye and 20\/25 in the left eye. On the basis of the multimodal imaging findings, the patient was diagnosed with Bietti crystalline retinal dystrophy with unilateral CME. Carbonic anhydrase inhibitor therapy twice a day was initiated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Three months later, visual acuity improved to 20\/25 in the right eye, and CME had resolved based on spectral domain ocular coherence tomography findings, although the CME reoccurred after discontinuation of the drug. Three months after resuming the therapy, the best-corrected visual acuity improved back to 20\/25.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Cystoid macular edema is one of the main causes of central visual worsening in patients with Bietti crystalline retinal dystrophy. This complication may be resolved with topical carbonic anhydrase inhibitor, resulting in improved anatomical and visual outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/icb.0000000000000792","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T01:24:00Z","timestamp":1532049840000},"page":"306-309","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["TOPICAL DORZOLAMIDE FOR CYSTOID MACULAR EDEMA IN BIETTI CRYSTALLINE RETINAL DYSTROPHY"],"prefix":"10.1097","volume":"15","author":[{"given":"Hassan","family":"Khojasteh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramak","family":"Roohipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Riazi-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrbod","family":"Ghasempour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archopht.1989.01070010219026","article-title":"Richard green. Bietti's crystalline dystrophy: a clinicopathologic correlative study","volume":"107","author":"DavidWilson","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"R2-20250507","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1001\/archophthalmol.2012.1567","article-title":"Bietti crystalline retinopathy: report of retinal crystal deposition in male adolescent siblings","volume":"130","author":"Manzouri","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.survophthal.2012.11.006","article-title":"Treatment of cystic macular lesions in hereditary retinal dystrophies","volume":"58","author":"Salvatore","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"R4-20250507","first-page":"51","article-title":"An overview of rare and unusual clinical features of Bietti's crystalline dystrophy","volume":"3","author":"Osman Saatci","year":"2014","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1167\/iovs.14-15995","article-title":"Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa","volume":"56","author":"Liew","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3341\/kjo.2014.28.2.189","article-title":"Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy","volume":"28","author":"Broadhead","year":"2014","journal-title":"Korean J Ophthalmol"},{"key":"R7-20250507","first-page":"964892","article-title":"Cystoid macular edema in Bietti's crystalline retinopathy","volume":"2014","author":"Saatci","year":"2014","journal-title":"Case Rep Ophthalmological Med"},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archophthalmol.2010.172","article-title":"Efficacy for sustained use of topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and Usher syndrome","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:17:26Z","timestamp":1746652646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000000792","relation":{},"ISSN":["1935-1089"],"issn-type":[{"value":"1935-1089","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}